Literature DB >> 18262645

Critical role of multidimensional flow cytometry in detecting occult leptomeningeal disease in newly diagnosed aggressive B-cell lymphomas.

R Di Noto1, G Scalia, G Abate, M Gorrese, C Pascariello, M Raia, P Morabito, F Capone, C Lo Pardo, P Mirabelli, E Mariotti, L Del Vecchio.   

Abstract

Among histological aggressive non-Hodgkin lymphomas (NHL), the overall risk of central nervous system (CNS) relapse is approximately 5%, a figure which is too low to offer prophylaxis to all patients. The aim of this work is to demonstrate the utility of flow cytometry (FCM) in detecting occult leptomeningeal disease in this subtype of NHL. We studied cerebrospinal fluid (CSF) involvement in 42 newly diagnosed aggressive NHL patients at risk for CNS involvement. We used multicolour FCM to detect CSF infiltrating neoplastic cells. Among the 42 patients studied, 11 had CSF involvement as detected by FCM. Of these, only four were also positive for conventional morphology (p=0.046). These results designate that FCM as the first choice technique in NHL CSF clinical cell analysis.

Entities:  

Mesh:

Year:  2008        PMID: 18262645     DOI: 10.1016/j.leukres.2007.12.016

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  7 in total

Review 1.  Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and Management.

Authors:  Shilpa Paul; Nicholas J Short
Journal:  Curr Oncol Rep       Date:  2022-02-10       Impact factor: 5.075

Review 2.  A systematic approach to the diagnosis of suspected central nervous system lymphoma.

Authors:  Brian J Scott; Vanja C Douglas; Tarik Tihan; James L Rubenstein; S Andrew Josephson
Journal:  JAMA Neurol       Date:  2013-03-01       Impact factor: 18.302

Review 3.  Central nervous system involvement in adult acute lymphoblastic leukemia: diagnostic tools, prophylaxis, and therapy.

Authors:  Maria Ilaria Del Principe; Luca Maurillo; Francesco Buccisano; Giuseppe Sconocchia; Mariagiovanna Cefalo; Giovanna De Santis; Ambra Di Veroli; Concetta Ditto; Daniela Nasso; Massimiliano Postorino; Marco Refrigeri; Cristina Attrotto; Giovanni Del Poeta; Francesco Lo-Coco; Sergio Amadori; Adriano Venditti
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-11-01       Impact factor: 2.576

4.  Usefulness of Flow Cytometric Analysis for Detecting Leptomeningeal Diseases in Non-Hodgkin Lymphoma.

Authors:  Sang Yong Shin; Seung Tae Lee; Hee Jin Kim; Young Lyun Oh; Seok Jin Kim; Won Seog Kim; Sun Hee Kim
Journal:  Ann Lab Med       Date:  2016-05       Impact factor: 3.464

5.  Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the Campus ALL Network.

Authors:  Maria Ilaria Del Principe; Elisa Buzzatti; Alfonso Piciocchi; Fabio Forghieri; Massimiliano Bonifacio; Federica Lessi; Silvia Imbergamo; Enrico Orciuolo; Giovanni Rossi; Nicola Fracchiolla; Silvia Trappolini; Benedetta Neri; Chiara Sarlo; Patrizia Zappasodi; Michelina Dargenio; Mariagiovanna Cefalo; Maria Antonietta Irno-Consalvo; Consuelo Conti; Giovangiacinto Paterno; Gottardo De Angelis; Mariarita Sciumè; Irene Della Starza; Adriano Venditti; Robin Foà; Anna Rita Guarini
Journal:  Haematologica       Date:  2021-01-01       Impact factor: 9.941

6.  Major Differences in Lymphocyte Subpopulations Between Cerebrospinal Fluid and Peripheral Blood in Non-Hodgkin Lymphoma Without Leptomeningeal Involvement: Flow Cytometry Evidence of a Cerebral Lymphatic System.

Authors:  Iole Cordone; Serena Masi; Diana Giannarelli; Alessia Pasquale; Laura Conti; Stefano Telera; Andrea Pace; Elena Papa; Mirella Marino; Paolo de Fabritiis; Andrea Mengarelli
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

7.  Cerebrospinal fluid findings in patients with hematologic neoplasms and meningeal infiltration.

Authors:  Renan Barros Domingues; Fernando Brunale Vilela de Moura Leite; Carlos Senne
Journal:  Acta Neurol Belg       Date:  2020-06-10       Impact factor: 2.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.